Maria Irno Consalvo

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia

Francesco Buccisano, Luca Maurillo, Valter Gattei et al. · Leukemia · 2006 · 132 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +8

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Francesco Buccisano, Luca Maurillo, Alessandra Spagnoli et al. · Blood · 2010 · 131 citations · Full text

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli et al. · Haematologica · 2007 · 89 citations · Full text

A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies <i>FLT3</i> -Mutated Clones in Acute Myeloid Leukemia

Daniela F. Angelini, Tiziana Ottone, Gisella Guerrera et al. · Clinical Cancer Research · 2015 · 81 citations · Full text

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

Adriano Venditti, Luca Maurillo, Francesco Buccisano et al. · Leukemia · 2003 · 72 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +13